Trevi Therapeutics, Inc. (TRVI)
NASDAQ: TRVI · Real-Time Price · USD
6.70
+0.10 (1.52%)
At close: May 12, 2025, 4:00 PM
6.60
-0.10 (-1.49%)
After-hours: May 12, 2025, 7:51 PM EDT
Trevi Therapeutics Employees
Trevi Therapeutics had 26 employees as of December 31, 2024. The number of employees increased by 1 or 4.00% compared to the previous year.
Employees
26
Change (1Y)
1
Growth (1Y)
4.00%
Revenue / Employee
n/a
Profits / Employee
-$1,821,115
Market Cap
681.69M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
TRVI News
- 1 day ago - Trevi Therapeutics, Inc. (TRVI) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 4 days ago - Trevi Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Updates - PRNewsWire
- 11 days ago - Trevi Therapeutics to Report First Quarter 2025 Financial Results and Provide a Corporate Update on May 8, 2025 - PRNewsWire
- 5 weeks ago - Trevi Therapeutics to Participate in Upcoming April Investor Conferences - PRNewsWire
- 7 weeks ago - Trevi Therapeutics, Inc. (TRVI) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 7 weeks ago - Trevi Therapeutics Reports Fourth Quarter and Year End 2024 Financial Results and Provides Business Updates - PRNewsWire
- 2 months ago - Trevi Therapeutics to Report Fourth Quarter and Year End 2024 Financial Results and Provide a Corporate Update on March 18, 2025 - PRNewsWire
- 2 months ago - Trevi Therapeutics Reveals Positive Data From Mid-Stage Study For Chronic Cough Candidate, Stock Jumps - Benzinga